Publications by authors named "M Kusaka"
Background: The concept of recovery has become internationally widespread. To promote personal recovery of individuals with mental disorders, it is important that they live life on their own terms. Many people with mental disorders wish to build intimate relationships and marry.
View Article and Find Full Text PDFObjectives: The optimal indication and survival benefits of prophylactic urethrectomy (PU) during radical cystectomy remain unclear. Therefore, this study aims to evaluate the impact of urethra-preserving surgery (UPS) on oncological outcome including its recurrence patterns, and to establish an optimal urethral management strategy with a novel UPS technique in the robotic era.
Patients And Methods: We retrospectively analyzed 281 male patients with bladder cancer who received radical cystectomy (RC) (115 with and 166 without PU) at our institutions between 2010 and 2023.
Article Synopsis
- * Results showed that the ERAS protocol significantly shortened hospital stays, improved bowel recovery, and reduced POI in non-frail patients, but it did not have the same benefits for frail patients.
- * The findings suggest that while ERAS is effective for non-frail patients, frail patients might require additional strategies, like prehabilitation, to better manage POI post-surgery.
Article Synopsis
- The study aimed to assess the safety and effectiveness of robot-assisted radical cystectomy with an intracorporeal ileal conduit in older patients (≥75 years) compared to younger patients (<75 years).
- A total of 122 patients were analyzed, showing no major differences in perioperative outcomes except for a longer hospital stay for older patients (19 days vs. 16 days).
- Despite some complications being more frequent in older patients, there were no significant differences in cancer recurrence or survival rates, suggesting that the procedure is safe and effective for older individuals.
Purpose: To investigate the predictors of macular chorioretinal atrophy, consisting of patchy atrophy (PA) at the macula and choroidal neovascularization (CNV)-related macular atrophy (CNV-MA), during treatment with ranibizumab or aflibercept for myopic CNV (mCNV) and its impact on visual outcomes.
Methods: This retrospective study included 82 eyes with treatment-naïve mCNV who were treated with pro re nata injections of ranibizumab or aflibercept.
Results: Nine eyes (11.